Viewing Study NCT05763992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-06-26 @ 12:59 PM
Study NCT ID: NCT05763992
Status: RECRUITING
Last Update Posted: 2023-05-18
First Post: 2023-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Triple Negative Breast Cancer View
None Dietary Exposure View
None Fasting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Triple Negative Breast Cancer View
None Neoadjuvant chemoimmunotherapy View
None Fasting-Like Approach View
None Immunometabolism View
None Pathologic Complete Responses (pCRs) View
None Randomized, phase II trial View